GB1009307A - Guanidine derivatives and acid-addition salts thereof - Google Patents

Guanidine derivatives and acid-addition salts thereof

Info

Publication number
GB1009307A
GB1009307A GB43580/62A GB4358062A GB1009307A GB 1009307 A GB1009307 A GB 1009307A GB 43580/62 A GB43580/62 A GB 43580/62A GB 4358062 A GB4358062 A GB 4358062A GB 1009307 A GB1009307 A GB 1009307A
Authority
GB
United Kingdom
Prior art keywords
compounds
formula
addition salts
reacting
represent hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB43580/62A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of GB1009307A publication Critical patent/GB1009307A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention comprises compounds of the general formula <FORM:1009307/C2/1> or their non-toxic acid addition salts, wherein R1 and R2 each represent hydrogen or C1- 3 alkoxy, or together C1- 3-alkylenedioxy; R3 and R4 each represent hydrogen or C1- 3-alkyl; and A represents C2- 5-alkylene and the preparation thereof by reacting a compound of the formula <FORM:1009307/C2/2> with a compound capable of forming with the primary amino group of the starting material, by condensation or addition, a guanidino group, and, if desired, converting a base formed into its acid addition salt. Compounds of formula II are prepared by reacting an appropriate 1,2,3,4,5,6-hexa-hydrobenzo[d]azocine with an haloalkylnitrile to form the corresponding nitrile and hydrogenating the latter. Pharmaceutical compositions comprise the compounds of formula I together with a pharmaceutically acceptable carrier and may be in a form for oral (e.g. tablets or dragees) or parenteral administration. The compounds are antihypertensive agents.
GB43580/62A 1961-11-20 1962-11-19 Guanidine derivatives and acid-addition salts thereof Expired GB1009307A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEA0038840 1961-11-20
SE884362 1962-08-14

Publications (1)

Publication Number Publication Date
GB1009307A true GB1009307A (en) 1965-11-10

Family

ID=25963668

Family Applications (1)

Application Number Title Priority Date Filing Date
GB43580/62A Expired GB1009307A (en) 1961-11-20 1962-11-19 Guanidine derivatives and acid-addition salts thereof

Country Status (3)

Country Link
DK (1) DK103127C (en)
FR (1) FR2710M (en)
GB (1) GB1009307A (en)

Also Published As

Publication number Publication date
FR2710M (en) 1964-08-10
DK103127C (en) 1965-11-22

Similar Documents

Publication Publication Date Title
GB1046506A (en) Guanidine compounds and process for their manufacture
ES363147A1 (en) Substituted phenylacetyl derivatives of guanidine o-alkylisoureas s-alkylisothioureas and p-nitrobenzylisothiourea
GB853799A (en) Diquaternary compounds and process of preparing same
ES8405005A1 (en) New ribofuranuronic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof.
GB1411583A (en) Aminophenyl-substituted alkyl-heterocyclic derivatives and processes for producing them
GB1228736A (en)
GB1113391A (en) Biologically active dithiosemicarbazones
GB1456627A (en) Pyridobenzodiazepinones
ES8600309A1 (en) Syn-isomer of 7-substituted-3-vinyl-3-cephem compounds, processes for production thereof and pharmaceutical compositions containing them.
GB1415471A (en) Phenylethylamine derivatives
GB1016071A (en) New guanidine derivatives and process for preparing the same
GB1009307A (en) Guanidine derivatives and acid-addition salts thereof
GB862721A (en) Dialkylaminoethyl derivatives of salicylamides
GB1120186A (en) Cyclohexene amino acid derivatives and process for their preparation
NZ512891A (en) S-oxide lipid lowering compounds
GB1142508A (en) Pyrrole derivatives
GB985635A (en) Guanidine derivatives and process for their production
GB1384523A (en) Oxime derivatives and their preparation
GB1501475A (en) Piperidinobutyrophenone derivatives
ES428535A1 (en) N-substituted cycloserine compounds, salts thereof, and processes for preparing them
GB1339010A (en) Tetrazolyl-anthraquinone derivatives
GB1023203A (en) Propylamine derivatives
ES368607A1 (en) 1-substituted-2 5-diphenylpyrroles
GB1193534A (en) Novel Benzazocine Derivatives, the Preparation thereof and Compositions Containing the same
GB1117125A (en) Derivatives of carbamic acid